Member of the Board of Advisors jobs in United States
cer-icon
Apply on Employer Site
company-logo

Radiatric ยท 4 months ago

Member of the Board of Advisors

Radiatric is a medical device company pioneering a novel light-based treatment platform designed to combat multi-drug-resistant organisms and reduce mortality from sepsis. They are seeking a senior healthcare executive to join their Advisory Board and guide the company through its next phase of clinical, regulatory, and commercial development.

Hospital & Health Care

Responsibilities

Advise on go-to-market strategy and payer/provider alignment
Support platform adoption in hospitals, critical care, and dialysis environments
Provide input on clinical safety, real-world workflows, and care economics
Connect Radiatric with healthcare systems, strategic partners, or public health agencies
Contribute to funding and grant efforts (e.g., BARDA-aligned applications)

Qualification

Healthcare administrationHealth tech leadershipProvider network strategyMedical devices experienceInfection controlCritical care deliveryReimbursement strategyInterest in care outcomes

Required

10+ years in healthcare administration, health tech leadership, or provider network strategy
Experience with medical devices, infection control, or critical care delivery
Understanding of reimbursement strategy and hospital purchasing
Interest in solutions that reduce mortality, prevent resistance, and improve care outcomes

Benefits

Receive equity in a growing digital health company
Help shape the future of chronic care and reduce provider burnout
Collaborate with mission-driven healthcare leaders
Early insight into key milestones (e.g., FDA and BARDA progress)
Visibility across strategic partnerships
The opportunity to collaborate with a seasoned team and scientific leaders in infectious disease, MedTech, and biodefense

Company

Radiatric

twitter
company-logo
Patent pending non-antibiotic investigational device for treating bacteremia and lowering pathogenic CFUs in extracorporeal blood to improve outcomes in bloodborne infections and severe sepsis.

Funding

Current Stage
Early Stage
Company data provided by crunchbase